Princeton, US, July 30, 2025: Everest Group, a leading global research and consulting firm, named Indegene a Leader in Life Sciences AI and Analytics Services for Commercial PEAK Matrix® Assessment 2025. Everest Group acknowledged Indegene’s wide-ranging AI and Analytics solutions across the life sciences commercial function, reinforcing its position as a trusted transformation partner for life sciences organizations.
Everest Group also commended Indegene’s continued efforts to embed Generative AI (GenAI) and Agentic AI capabilities across its commercial solutions portfolio, including investments in conversational AI, content summarization engines, and multi-agent orchestration frameworks to drive intelligent, contextualized automation. The report highlighted Indegene’s unique ability to combine its AI and Analytics capabilities with deep domain knowledge to deliver contextualized commercial solutions across a broad portfolio of therapy areas, including specifically tailored solutions for emerging therapy areas such as specialty care, oncology and rare diseases.
“The growing emphasis on patient - and HCP-centricity to deliver superior customer experiences has modernized commercialization strategies, placing data, analytics, and AI at the core of life sciences enterprises' go-to-market efforts. As a result, they are turning to strategic partners with domain-led digital expertise and scalable technology solutions to navigate the evolving landscape,” said Durga Ambati, Practice Director at Everest Group. “Indegene’s broad portfolio of solutions within its NEXT platform, as well as its continued investments in embedding GenAI and Agentic AI across its capabilities, are well-complemented by its diverse therapeutic knowledge and strong market-facing assets. These factors have led to Indegene earning a Leader position in Everest Group’s Life Sciences AI and Analytics Services for Commercial PEAK Matrix® Assessment 2025.”
Indegene’s unified, enterprise-wide AI approach embeds production-ready solutions across commercial operations. This strategy is already helping life sciences companies achieve significant operational efficiencies and productivity gains, and accelerating their journey towards being future-ready.
“Advancements in AI and analytics are enabling life sciences companies to modernize and transform their business operations with an AI-first, data-driven approach”, said Vivek Ghai, EVP-Enterprise Commercial Solutions, Indegene. “Our focus is on helping clients scale AI responsibly - prioritizing use cases that drive measurable outcomes, integrating seamlessly with enterprise ecosystems, and delivering solutions that are not just innovative, but production-ready from day one. Everest Group’s recognition validates our ability to translate advanced AI into real-world value for our clients.”

Everest Group assessed 30 service providers on their AI and Analytics vision, capabilities, and market impact. The evaluation criteria included vision and strategy, scope of services, innovation and investments, delivery footprint, market adoption, portfolio mix, and client value delivered.
To download the full report, click here.
Indegene combines deep healthcare expertise with a digital-first approach to help pharma, biotech, and medical device companies commercialize their products. Its client base includes the world’s top 20 biopharma companies, many emerging biotech firms, and medical device companies. Indegene has around 5,000 employees worldwide, 9 operations hubs and 19 offices across North America, Europe, and Asia.
Indegene Limited (BSE: 544172, NSE: INDGN) is a digital-first, life sciences commercialization company. It helps biopharmaceutical, emerging biotech and medical device companies develop products, get them to the market, and grow their impact through the life cycle in a more effective, efficient and modern way. Indegene brings together healthcare domain expertise, fit-for-purpose technology and an agile operating model to provide a diverse range of solutions. These aim to deliver, amongst other outcomes, a personalized, scalable and omnichannel experience for patients and physicians. It’s what drives Indegene’s team and their purpose to enable healthcare organizations to be future-ready. To learn more, please visit www.indegene.com
Licensed extracts taken from Everest Group’s PEAK Matrix® Reports may be used by licensed third parties for use in their own marketing and promotional activities and collateral. Selected extracts from Everest Group’s PEAK Matrix® reports do not necessarily provide the full context of our research and analysis. All research and analysis conducted by Everest Group’s analysts and included in Everest Group’s PEAK Matrix® reports is independent, and no organization has paid a fee to be featured or to influence their ranking. To access the complete research and to learn more about our methodology, please visit Everest Group PEAK Matrix® Reports.
Everest Group is a leading global research firm helping business leaders make confident decisions. Everest Group's PEAK Matrix® assessments provide the analysis and insights enterprises need to make critical selection decisions about global services providers, locations, and products and solutions within various market segments. Likewise, providers of these services, products, and solutions, look to the PEAK Matrix® to gauge and calibrate their offerings against others in the industry or market. Find further detailsand in-depth content at www.everestgrp.com.